UCB SA (UCBJY)
69.68
+1.26
(+1.84%)
USD |
OTCM |
May 31, 16:00
UCB Enterprise Value: 28.46B for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 28.46B |
| May 30, 2024 | 27.98B |
| May 29, 2024 | 28.07B |
| May 28, 2024 | 28.19B |
| May 24, 2024 | 28.41B |
| May 23, 2024 | 28.45B |
| May 22, 2024 | 28.16B |
| May 21, 2024 | 28.44B |
| May 20, 2024 | 28.10B |
| May 17, 2024 | 27.68B |
| May 16, 2024 | 27.00B |
| May 15, 2024 | 27.28B |
| May 14, 2024 | 26.72B |
| May 13, 2024 | 26.98B |
| May 10, 2024 | 27.12B |
| May 09, 2024 | 26.40B |
| May 08, 2024 | 26.70B |
| May 07, 2024 | 26.47B |
| May 06, 2024 | 26.49B |
| May 03, 2024 | 26.63B |
| May 02, 2024 | 26.90B |
| May 01, 2024 | 27.31B |
| April 30, 2024 | 27.15B |
| April 29, 2024 | 27.09B |
| April 26, 2024 | 27.24B |
| Date | Value |
|---|---|
| April 25, 2024 | 27.56B |
| April 24, 2024 | 26.60B |
| April 23, 2024 | 26.78B |
| April 22, 2024 | 26.66B |
| April 19, 2024 | 26.51B |
| April 18, 2024 | 26.18B |
| April 17, 2024 | 26.33B |
| April 16, 2024 | 26.04B |
| April 15, 2024 | 25.92B |
| April 12, 2024 | 26.26B |
| April 11, 2024 | 25.95B |
| April 10, 2024 | 25.52B |
| April 09, 2024 | 25.47B |
| April 08, 2024 | 25.60B |
| April 05, 2024 | 25.47B |
| April 04, 2024 | 25.64B |
| April 03, 2024 | 25.61B |
| April 02, 2024 | 25.43B |
| April 01, 2024 | 25.33B |
| March 28, 2024 | 25.40B |
| March 27, 2024 | 25.38B |
| March 26, 2024 | 25.50B |
| March 25, 2024 | 25.72B |
| March 22, 2024 | 25.46B |
| March 21, 2024 | 24.97B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
11.93B
Minimum
Mar 18 2020
28.46B
Maximum
May 31 2024
19.36B
Average
19.04B
Median
May 05 2021
Enterprise Value Benchmarks
| Galapagos NV | -2.010B |
| Mithra Pharmaceuticals SA | -- |
| Nyxoah SA | 231.17M |
| Celyad Oncology SA | -- |
| MDxHealth SA | 96.70M |
Enterprise Value Related Metrics
| Earnings Yield | 1.38% |
| Operating Earnings Yield | 2.53% |
| Normalized Earnings Yield | 1.369 |